
Aplixa Pharma Private Limited
About Aplixa Pharma Private Limited
Data last updated:
Aplixa Pharma Private Limited is a private limited company based in Ujjain, Madhya Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 09 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2019PTC049087.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Seema Singh Kumari and Ranjeet Jha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 14/2 Triveni Hills Indore Road Mahananda, Ujjain, Madhya Pradesh, India – 456010.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.2 Lakh, a decline of 42% compared to the previous year. Revenue has declined at a compounded annual rate (CAGR) of 14% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address14/2 Triveni Hills Indore Road Mahananda, Ujjain, Madhya Pradesh, India – 456010
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Aplixa Pharma Private Limited
The main business activity of Aplixa Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Aplixa Pharma Private Limited FY 2025 filings available
Aplixa Pharma Private Limited reported revenue of ₹2.2 Lakh (down 42% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Aplixa Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 14% over three years, including a 42% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Aplixa Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Aplixa Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aplixa Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Aplixa Pharma Private Limited
Aplixa Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Covers Cart India Private Limited | ₹2.2 Lakh (FY 2016) | •••• | •••• | 4.0% | •••• | New Delhi, Delhi, India |
| Ryanscot Pharmaceuticals Private Limited | ₹2.2 Lakh (FY 2023) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Aplixa Pharma Private Limited this company | ₹2.2 Lakh (FY 2025) | •••• | •••• | -42.0% | •••• | Ujjain, Madhya Pradesh, India |
| Technaus Solar Private Limited | ₹2.2 Lakh (FY 2018) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Chanda Cast Iron Industries Pvt Ltd | ₹2.2 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Kolkata, West Bengal, India |
| Subh Vardaan Business Solutions Private Limited | ₹2.2 Lakh (FY 2019) | •••• | •••• | •••• | Karnal, Haryana, India | |
| Treatit India Private Limited | ₹2.2 Lakh (FY 2025) | •••• | •••• | 85.0% | •••• | Chennai, Tamil Nadu, India |
| Hem Ganga Polytex Pvt.Ltd. | ₹2.2 Lakh (FY 2024) | •••• | •••• | 1.0% | •••• | Ramnagar, Uttar Pradesh, India |
| Shree Nidhi Manufacturing & Designing Private Limited | ₹2.2 Lakh (FY 2016) | •••• | •••• | -99.0% | •••• | Surat, Gujarat, India |
| GSB Chem India Private Limited | ₹2.2 Lakh (FY 2022) | •••• | •••• | •••• | Rudrapur, Uttarakhand, India | |
| Nsk-R Engineering Solutions Private Limited | ₹2.2 Lakh (FY 2024) | •••• | •••• | -28.0% | •••• | Kattupakkam, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Aplixa Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Aplixa Pharma Private Limited
Aplixa Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Seema Singh Kumari Also directs: Sublime Polynet Private Limited | Director | 09 Jul 2019 | 7 Years 3 Months | Current |
| Ranjeet Jha Also directs: Sublime Polynet Private Limited | Director | 09 Jul 2019 | 7 Years 3 Months | Current |
| Varun Singh | Director | 09 Jul 2019 | 7 Years 3 Months | Current |
Charges & Borrowings of Aplixa Pharma Private Limited
Aplixa Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Aplixa Pharma Private Limited
Employment history and EPFO contributions of people linked to Aplixa Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Aplixa Pharma Private Limited
Aplixa Pharma Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Ranjeet Jha was appointed as Director on 09 Jul 2019.
Credit Ratings, Litigation & Regulatory Alerts for Aplixa Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aplixa Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aplixa Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aplixa Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aplixa Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aplixa Pharma Private Limited
Aplixa Pharma is an active private limited company based in Ujjain, Madhya Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 09 July 2019 (7+ years old) and is registered under CIN U24230MP2019PTC049087.
Aplixa Pharma reported revenue of ₹2.2 Lakh for FY 2025 (down 42% YoY).
Aplixa Pharma has 3 current directors:
- Seema Singh Kumari - Director
- Ranjeet Jha - Director
- Varun Singh - Director
The compounded annual growth rate (CAGR) of the revenue of Aplixa Pharma is -14% over three years. In the latest year (FY 2025) revenue fell 42%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Aplixa Pharma is U24230MP2019PTC049087. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aplixa Pharma was incorporated on 09 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Aplixa Pharma by revenue are Covers Cart India Private Limited, Ryanscot Pharmaceuticals Private Limited, Technaus Solar Private Limited, Chanda Cast Iron Industries Pvt Ltd, Subh Vardaan Business Solutions Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Ranjeet Jha was appointed as Director on 09 Jul 2019. Seema Singh Kumari was appointed as Director on 09 Jul 2019. Varun Singh was appointed as Director on 09 Jul 2019.
The registered office of Aplixa Pharma is at 142 Triveni Hills Indore Road Mahananda, Ujjain, Madhya Pradesh, India – 456010.
Aplixa Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Aplixa Pharma operates in the chemicals industry, in the manufacturing segment.